Cargando…
Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases
Patients with metastatic prostate cancer (PCa) have a poorer prognosis than patients with organ-confined tumors. We strove to uncover the proteome signature of primary PCa and associated lymph node metastases (LNMs) in order to identify proteins that may indicate or potentially promote metastases fo...
Autores principales: | Müller, Ann-Kathrin, Föll, Melanie, Heckelmann, Bianca, Kiefer, Selina, Werner, Martin, Schilling, Oliver, Biniossek, Martin L., Jilg, Cordula Annette, Drendel, Vanessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735259/ https://www.ncbi.nlm.nih.gov/pubmed/29248718 http://dx.doi.org/10.1016/j.neo.2017.10.009 |
Ejemplares similares
-
Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas
por: Drendel, Vanessa, et al.
Publicado: (2018) -
Proteome profiling of clear cell renal cell carcinoma in von Hippel-Lindau patients highlights upregulation of Xaa-Pro aminopeptidase-1, an anti-proliferative and anti-migratory exoprotease
por: Drendel, Vanessa, et al.
Publicado: (2017) -
Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer
por: Jilg, Cordula A., et al.
Publicado: (2017) -
Fingerprinting Lymph Node Metastases
por: Symmans, W. Fraser, et al.
Publicado: (2008) -
Voxel-based comparison of [(68)Ga]Ga-RM2-PET/CT and [(68)Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
por: Fassbender, Thomas Franz, et al.
Publicado: (2020)